ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,203, issued on June 24, was assigned to TAISHO PHARMACEUTICAL Co. LTD. (Tokyo).
"Urea compound for antagonizing LPA1 receptor" was invented by Shoichi Kuroda (Tokyo), Yuki Kobayashi (Tokyo), Kanako Hatanaka (Tokyo), Yuji Ito (Tokyo), Fumito Uneuchi (Tokyo) and Yuko Uehara (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof which has the effect of antagonizing the LPA1 receptor."
The patent was filed on July 29, 2020, under Application No. 17/629,955.
*For further information, including images, charts and tables, please visit: http:/...